Amy Feldman is a Forbes senior editor, covering healthcare, based in New York. She’s written features on Jennifer Doudna’s $1 billion plan for gene-editing, Apnimed’s sleep apnea pill, Fred Moll’s surgical robotics investments, OpenEvidence, Axsome’s Herriot Tabuteau and Bell
Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.
Public Health Officials Believe The Hantavirus Outbreak Is Under Control
In this week’s edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more.
This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time
NVision reaises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.
Billions In Prescriptions Go Unfilled. This Startup Is Using AI To Fix That.
Forus reached $1 billion valuation by dealing with the unglamorous admin work of processing scripts so patients can get the drugs they need.
First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s
Indian billionaire Dilip Shanghvi’s plans to expand his healthcare empire in the U.S., the hantavirus outbreak on a cruise ship, and more
Using AI To Personalize Healthcare–Without Losing Patient Trust
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors to buy stalled drugs and use AI to stress test them faster.
This Pill May Help Pancreatic Cancer Patients Live Longer
In this week’s edition of InnovationRx, we look at the top self-made healthcare entrepreneurs, the latest 30 Under 30 Science & Healthcare list, and more.
30 Under 30 Europe Science & Healthcare 2026: The Founders Using AI To Empower Patients And Unlock Scientific Mysteries
These young entrepreneurs, researchers and doctors are improving healthcare, empowering patients and building the hardware of the future.
Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest
In this week’s edition of InnovationRx, we look at the first robotic cataract surgeries in humans, the underbelly of marketing compounded GLP-1s, and more.